Opinion pieces published in TechEchelon are written by outside contributors. Guest contributors are not employees or staff of TechEchelon, and the views expressed are their own and do not necessarily reflect those of the publication. Each contributor's full bio appears in italics at the foot of their article.
In November 2022, a fake tweet claiming Eli Lilly would begin giving away insulin for free went viral on Twitter. The tweet wasn’t from the company’s official account, but it was convincing enough and amplified quickly enough that it caused Eli Lilly’s stock to plunge and triggered chaos across the pharmaceutical sector.
152 DAYS AGO
“If you put the federal government in charge of the Sahara Desert, in five years there'd be a shortage of sand.”
994 DAYS AGO
Written for readers who already know the basics — markets, AI, and the policy decisions that shape both.